That was last week, but I had no time to listen until now - check out the podcast (in the upper left corner of the page):
In 1989, Dr. Harold Varmus won a Nobel Prize for his cancer research. He was director of the National Institutes of Health during the Clinton administration, and now heads the Memorial Sloan-Kettering Cancer Center. Recently, President Obama named him to co-chair his Council of Advisers on Science and Technology. And he's written a new book, "The Art and Politics of Science." In this segment, Ira talks with Harold Varmus about his work, biological research, and the intersection between politics and science.
- Log in to post comments
More like this
Listen here to the The December 16, 2008 David E. Barmes Global Health Lecture given by Dr.Harold Varmus:
Harold Varmus, former Director of the National Institutes of Health and co-recipient of a Nobel Prize for studies of the genetic basis of cancer, is President of Memorial Sloan-Kettering Cancer…
A Hurdle for Health Reform: Patients and Their Doctors:
Dr. Harold Varmus, the president of Memorial Sloan-Kettering Cancer Center in New York and a former director of the National Institutes of Health, said increasing public access to the findings of medical research would be important for health…
There's an advertising feature in the latest GQ that champions 17 "Rock Stars of Science." Each ad includes a genuine rock music star alongside three or four genuine scientists, some Nobel laureates among them. The idea is to make science sexy.
Will it work? Chris Mooney, co-author of Unscientific…
Out of all the suggestions that have been thrown around about who should be the next Presidential science advisor, I think Bora over at A Blog Around the Clock might have hit on the best choice and that's Harold Varmus.
As I noted in a previous post discussing the possibility of Francis Collins as…
in addition to 'art' and 'politics' of science, there is 'greed' and 'disingenuousness'; for a summary of ethics and safety concerns at a high profile cancer research center (mskcc), please see: www.mskccheats.blogspot.com; âSloan is pursuing a systemic approach to reducing expenses and increasing revenues [â¦] One example of this is discouraging terminally ill patients from seeking initial treatment or second opinions from the cancer center [â¦] the admission of such patients is counterproductive [â¦] to Sloan Kettering.â [paraphrasing salient features, MSKCC, CFO/Chief Financial Officer]; mskcc, we hoped you'd be our hero. Minimally, you're SUPPOSED to care. Who would build a laboratory building and knowingly NOT install ductwork controls? MSKCC did. Who would terminate under false pretense employees who rightfully complain about safety/health factors only to have to abandon a building for safety/health factors (carbon monoxide exposure to employees)? MSKCC did! Ed Mahoney currently heads mskcc facilities. Attorney Shelly Friedman represents mskcc when it attempts to assuage rightfully concerned community members relative to environmental health and safety issues concomitant with expansion. Why would a non-clinician instruct a coworker to mislead (embargo) known information as to the availability of a clinical trial candidate at mskcc, created by a competitor, when the in house version of the drug had not yet made it out of the proverbial clinical trial gate? Sarah Danishefsky of mskcc did. Boo. You know better.